Pfizer vs Amgen: Revenue Comparison
Pfizer (PFE) and Amgen (AMGN) are peers in GLP-1. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $8.6B for Amgen. Pfizer leads on revenue.
Pfizer's gross margin is 67.3% versus 68.2% for Amgen. Pfizer's net margin is 18.6% versus 21.1% for Amgen.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, Amgen 8.618.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Amgen.| Metric | Pfizer | Amgen |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $8.62B |
| Cost of Revenue | $4.73B | $2.74B |
| Gross Profit | $9.72B | $5.87B |
| Operating Income | $4.03B | $2.67B |
| Net Income | $2.69B | $1.82B |
| R&D Expense | $2.63B | $1.72B |
| Earnings Per Share | $0.47 | $3.34 |
| Gross Margin | 67.3% | 68.2% |
| Operating Margin | 27.9% | 30.9% |
| Net Profit Margin | 18.6% | 21.1% |
| Free Cash Flow | $2.18B | $1.48B |
| Cumulative Free Cash Flow | $356.40B | $165.69B |
| Operating Cash Flow | $2.62B | $2.19B |
| Cash & Equivalents | $1.70B | $12.04B |